2018

1. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

   The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060